Skip to main content
Fig. 3 | Breast Cancer Research

Fig. 3

From: A subgroup of microRNAs defines PTEN-deficient, triple-negative breast cancer patients with poorest prognosis and alterations in RB1, MYC, and Wnt signaling

Fig. 3

Expression analysis of frequently altered breast cancer genes in the PTEN-low/miR-low subgroup of TNBC. Heatmap for expression of 93 cancer genes in 31 PTEN(−) TNBC (a). ANOVA analysis of genes with significantly altered expression in PTEN-low/miR-low subgroup “a,” subgroups “b” and “c” or PTEN(+) TNBC (b). Scatter plots of selected genes with differentially altered expression in the PTEN/miRs groups in 205 TNBCs (c)

Back to article page